Benethera
PrivateLast Round
Series A
May 21, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Benethera operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series A round in May 2026.
Benethera is a biopharmaceutical company that develops innovative Treg-based small molecule and cell drug products for the treatment of autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Benethera Comparables
Compare Benethera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GentiBio | 83% | |
| Quell Therapeutics | 81% | |
| NImmune Biopharma | 80% |
For institutional investors. Book with your work email.
Benethera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 21, 2026 | ||||
| Pre Seed | Jul 28, 2023 | ||||
| Angel | Dec 31, 2022 | ||||
| Angel | Dec 15, 2021 |
For institutional investors. Book with your work email.
Benethera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lapam Capital | Pre Seed, Series A |
| Fudan Science and Technology Innovation Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
Raised Series A led by Fudan Science and Technology Innovation Fund and Lapam Capital.
- Dec 15, 2021
Completed an Angel funding round.
For institutional investors. Book with your work email.
Benethera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Benethera's valuation, stock price, and market status.
Is Benethera a public or private company?
Benethera is a private company.
What is the current stock price of Benethera?
Benethera is a private company, so its shares have no public market price. Caplight tracks Benethera's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Benethera worth (valuation)?
Valuation information for Benethera is not publicly available.
Can I buy Benethera stock?
Benethera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Benethera's last funding round?
Benethera's most recent funding round was Series A on May 21, 2026.
Who are the main investors in Benethera?
Key investors in Benethera include Lapam Capital, Fudan Science and Technology Innovation Fund.
Will Benethera IPO soon?
No public IPO plans have been announced for Benethera.
How can I track Benethera secondary market activity?
Caplight tracks bids, offers, and trades in Benethera's shares on secondary markets.